Parkinson’s and pesticides: the environmental question Parkinson’s research can no longer ignore

Richard Moore
5 days ago
14 min read

This is not a fringe question anymore

The link between Parkinson’s disease and pesticides has moved from the margins of the conversation to the centre of it, largely because the evidence base has become harder to dismiss. In recent years, the strongest papers have become more precise about which chemicals they are talking about, how exposure is estimated, and which biological pathways may be involved, rather than treating “pesticides” as one vague, undifferentiated category (Dorsey et al., 2025; Amaral et al., 2025). That does not mean the science is settled, and it certainly does not mean every exposed person will develop Parkinson’s disease. It does mean the question is now serious enough that it deserves careful, sober treatment rather than either panic or dismissal.

That nuance matters because Parkinson’s disease is not a single-cause condition. Most cases are still considered sporadic, meaning they are not explained by a single inherited mutation, and recent reviews argue that environmental toxicants, including some pesticides, are among the most plausible modifiable contributors to at least part of the current disease burden (Dorsey et al., 2025; Meerman et al., 2025). At the same time, those same reviews stop well short of saying that pesticides explain all, or even most, Parkinson’s disease. This is a multifactorial disease, and the current evidence points toward interaction, not simplicity.

The bigger picture: this is about long-term burden, not one dramatic exposure

At the population level, the pesticide story is not really about one dramatic poisoning event. It is about whether repeated exposure over years or decades, especially in agricultural and occupational settings, may gradually increase risk by adding stress to already vulnerable biological systems (Dorsey et al., 2025). That exposure may come through inhalation, skin contact, drift from nearby application, contaminated dust, or take-home exposure on clothes and equipment (Paul et al., 2024), and newer studies are trying much harder than older ones did to reconstruct those patterns rather than relying only on memory.

An influential recent example is the California Central Valley study by Paul and colleagues (2024), which assessed 829 Parkinson’s disease cases and 824 controls and reconstructed long-term ambient paraquat exposure using historical pesticide use reporting data and land-use information. They reported that paraquat exposure at both home and workplace was associated with higher odds of Parkinson’s disease, with some of the stronger estimates seen for workplace exposure and for people diagnosed at age 60 years or younger. That kind of design matters because it is materially stronger than simply asking participants to remember what they were exposed to many years earlier.

Another key study is the 2020 Agricultural Health Study analysis by Shrestha and colleagues, which followed licensed pesticide applicators and their spouses and looked at incident Parkinson’s disease, not just disease that had already been diagnosed (Shrestha et al., 2020). This study did not support a blanket statement that all pesticides carry the same risk. Instead, it found elevated risk for some compounds, including terbufos, trifluralin, and 2,4,5-trichlorophenoxyacetic acid, while many other associations were null. That is important because it tells us the field is dealing with heterogeneity, not a single uniform exposure story.

That heterogeneity is one of the strongest reasons this topic needs a balanced tone. The best reading of the literature is not “pesticides cause Parkinson’s disease” in an undifferentiated sense. It is that some pesticide exposures appear more relevant than others, that the quality of exposure assessment matters enormously, and that host susceptibility probably shapes risk (Shrestha et al., 2020; Dorsey et al., 2025).

The smaller picture: where the biology starts to make sense

The reason this field has become more persuasive is not just epidemiology. It is that many of the pesticides repeatedly discussed in the Parkinson’s disease literature affect the same systems that are already central to Parkinson’s disease biology. Recent mechanistic reviews describe recurring involvement of mitochondrial dysfunction, oxidative stress, impaired autophagy, proteasomal dysfunction, altered dopamine handling, and alpha-synuclein-related pathology (Amaral et al., 2025; Morris et al., 2024). Those are not peripheral details. They sit very close to the core of how Parkinson’s disease is currently understood.

For a general reader, the easiest way to picture this is to imagine a dopamine-producing nerve cell as a city. Its mitochondria are the power stations. Its autophagy and lysosomal systems are the waste collection and recycling services. Alpha-synuclein is a protein cargo that needs to be folded, moved, and cleared properly. Some pesticides appear able to cut the power, slow the waste-disposal systems, and increase the build-up of cellular rubbish at the same time. Dopamine-producing cells appear particularly poor at tolerating that kind of combined strain (Morris et al., 2024; Amaral et al., 2025).

This is why chemicals such as paraquat, rotenone, and more recently chlorpyrifos keep reappearing in the literature. Paraquat is associated with reactive oxygen species generation through redox cycling, which means it can intensify oxidative injury (Amaral et al., 2025). Rotenone is classically linked to inhibition of mitochondrial complex one, which interferes with energy production (Amaral et al., 2025). A 2025 paper in Molecular Neurodegeneration on chlorpyrifos added another layer by combining human exposure modelling with animal work and reported an association with higher Parkinson’s disease risk alongside evidence consistent with impaired autophagy, dopamine-neuron injury, and synuclein-related pathology (Hasan et al., 2025). The details differ by chemical, but the recurring pattern is convergence on systems that Parkinson’s disease already strains.

Mechanistic plausibility does not prove human causation by itself, but it matters. When observational epidemiology and laboratory biology begin to point toward the same vulnerable processes, the overall argument becomes more coherent (Amaral et al., 2025; Morris et al., 2024).

Landmark papers, and what they do and do not prove

The Paul et al. (2024) paraquat paper is important because it improved exposure assessment and still found a signal. Its strength lies in the reconstruction of exposure using objective agricultural records rather than memory alone. Its weakness is that it is still observational. Living or working near pesticide application is not identical to measuring the amount that entered someone’s body over decades, and residual confounding remains possible. So it is a strong paper, but not a final answer.

The Agricultural Health Study paper by Shrestha and colleagues (2020) is also important because it followed a farming population prospectively and showed that the signal is not equally strong across all compounds. That selective pattern is arguably a strength rather than a weakness, because it suggests the field is identifying specific risk candidates rather than simply finding a general association with agricultural life. Its limitation is that exposure was still based on reported use and not repeated biomonitoring, and the number of Parkinson’s disease cases for some pesticide-specific analyses remained modest.

The newer chlorpyrifos paper (Hasan et al., 2025) is notable because it tries to bridge the usual divide between epidemiology and mechanism. That is valuable, but it still needs replication and broader external validation before it should be treated as definitive. One strong paper can move the field, but not close it.

Genes and susceptibility: why exposure may not mean the same thing for everyone

The next layer of the story is susceptibility. A growing body of work suggests that the same pesticide exposure may not carry the same biological meaning for everyone, because gene-related differences in cellular repair, lysosomal function, mitochondrial resilience, and toxicant handling may modify vulnerability. A 2025 semi-systematic review in NAM Journal reached exactly that conclusion, highlighting susceptibility factors related to toxicokinetics, mitochondrial functioning, neurotransmission, and proteostasis (Meerman et al., 2025).

The clearest currently discussed genes are not the more familiar detoxification-related candidates that often dominate popular discussion, but genes already central to Parkinson’s disease biology. Brown and colleagues (2024) reported that occupational pesticide exposure may increase penetrance in people carrying risk variants in glucocerebrosidase (GBA) and may also be associated with faster symptom progression. They also studied leucine-rich repeat kinase 2 (LRRK2), although the evidence was stronger for GBA-related Parkinson’s disease. Related work has also pointed toward lysosomal and autophagy-linked genes. That makes mechanistic sense: if a person already has less robust intracellular clean-up and recycling, then an environmental exposure that further disrupts those systems may have more room to do damage.

But this is also where scientific restraint matters. These data do not justify telling individuals that a commercial genetic test can predict, with clinical confidence, how they personally will respond to pesticides over a lifetime (Meerman et al., 2025). The gene–environment literature is promising, but it is still limited by sample size, exposure measurement, population specificity, and replication gaps. The fair conclusion is that susceptibility likely differs between people, not that consumer genomics has already solved who is at risk.

The counterarguments: what a fair blog should say plainly

A balanced article has to say out loud that the evidence is not uniformly positive across all settings. One recent example is the 2024 Parkinson’s Progression Markers Initiative analysis of household pesticide exposure (Santos-Lobato et al., 2024). In that cohort, the investigators did not find an association between higher use of specific household pesticide groups and the odds of developing Parkinson’s disease, nor clear associations with several progression outcomes. They did, however, observe faster cognitive dysfunction with higher household fungicide exposure. That is not a clean refutation of the pesticide hypothesis, but it is a reminder that household exposure is not the same as agricultural exposure, and that not every dataset produces the same pattern.

There is also a regulatory counterpoint. The United States Environmental Protection Agency states on its paraquat page that studies on paraquat and Parkinson’s disease vary in quality and provide conflicting results (U.S. Environmental Protection Agency, 2025). That does not mean there is no signal. It means the evidentiary threshold for regulatory certainty and the evidentiary threshold for scientific concern are not always identical.

Methodological objections also remain legitimate. Earlier case–control work in this field was especially vulnerable to recall bias, because people with a diagnosis may remember or report past chemical exposure differently from people without one. Even the stronger modern studies still struggle with a major problem: long-term pesticide exposure is difficult to measure precisely in humans over decades (Paul et al., 2024). That is why no serious researcher should pretend that causality is proved in the same way it would be in an ideal experimental model.

So the honest position is this: the evidence is strong enough to warrant concern, strongest for some compounds and settings, but still incomplete enough that overstatement would be a mistake (Dorsey et al., 2025).

Nutrition, lifestyle, and “detoxification”: what can actually be said

This is the point where the conversation can easily run ahead of the evidence. At present, the strongest human studies do not support a supplement-led detoxification strategy for Parkinson’s-related pesticide risk. What they support more clearly is lowering the amount of pesticide coming in.

The clearest nutrition evidence comes from dietary intervention studies measuring urinary pesticide biomarkers. Hyland and colleagues (2019) showed that an organic diet intervention significantly reduced urinary levels of several pesticide metabolites and parent compounds in United States children and adults. Fagan and colleagues (2020) reported substantial reductions in urinary glyphosate and aminomethyl phosphonic acid after a short fully organic diet intervention. Rempelos and colleagues (2022) strengthened this with a randomised controlled dietary trial showing that total urinary pesticide residue excretion was markedly lower during an organic Mediterranean diet than during a conventional Mediterranean diet. These studies support the idea that pesticide burden from food is modifiable. They do not prove that changing diet prevents Parkinson’s disease or slows its progression.

That distinction is worth holding onto. Lower urinary residues are meaningful, but they are still exposure markers, not disease endpoints. A careful reading of the literature should not quietly slide from one to the other.

Food handling also matters, though imperfectly. The U.S. Environmental Protection Agency (2025) advises washing and scrubbing produce under running water, peeling where appropriate, discarding outer leaves of leafy vegetables, and eating a variety of foods from a variety of sources to reduce the chance of repeated exposure to the same residues. The agency also makes clear that washing does not remove every residue. That is particularly relevant for systemic pesticides, which are taken up into plant tissues rather than merely sitting on the surface.

At home, a prevention-first strategy also belongs in this discussion. The EPA’s guidance on family pesticide exposure recommends integrated pest management, including sealing entry points, reducing food and water sources for pests, monitoring early, and using traps, gels, baits, or spot treatments rather than defaulting to broad indoor pesticide use (U.S. Environmental Protection Agency, 2023). From a toxicology perspective, the body’s best support is often simply having less to process.

What about supplements?

This is the thinnest part of the evidence, so it needs the tightest language. A 2024 review in Frontiers in Nutrition argued that nutraceuticals including vitamins, minerals, antioxidants, and polyphenols may help mitigate the toxic effects of pesticide residues (Sajad et al., 2024), but that paper is a review of potential, not proof of a Parkinson’s-specific clinical detoxification model.

One of the few human intervention papers worth mentioning is the 2022 study by Medithi and colleagues in 129 farm children exposed to pesticides in Telangana, India. After thirty days of multivitamin and multimineral supplementation, the investigators reported that five organophosphorus pesticide residues were detectable before supplementation, whereas only chlorpyrifos and diazinon remained detectable afterwards, alongside improvements in acetylcholinesterase activity and reductions in lipid peroxidation markers (Medithi et al., 2022).

On the surface, that sounds encouraging, but it needs to be interpreted carefully. This was a before-and-after intervention in farm children, not a randomised placebo-controlled trial in adults, not a Parkinson’s disease cohort, and not a study of long-term neurological outcomes. The authors themselves noted that further research is needed to clarify the ameliorating effect of micronutrients in preventing adverse effects of organophosphorus pesticides (Medithi et al., 2022).

So, while it is reasonable to say that micronutrient adequacy may matter in populations living under ongoing pesticide stress, it would not be accurate to claim that multinutrient supplementation has been shown to detoxify pesticides in a way that prevents Parkinson’s disease (Medithi et al., 2022).

There is also mechanistic interest in N-acetylcysteine, because it relates to glutathione biology and redox defence. A 2025 review described it as a potential therapeutic agent against pesticide toxicity (Singh et al., 2025). That makes it biologically plausible, particularly in the context of oxidative stress, but plausible is not the same as established, and the current evidence does not support presenting N-acetylcysteine as a validated Parkinson’s-related pesticide detoxification therapy.

Sulforaphane, the compound derived from cruciferous vegetables and especially broccoli sprouts, is another biologically plausible candidate because clinical and mechanistic reviews describe its effects on antioxidant and phase-two detoxification pathways (Saito et al., 2025). That makes it relevant to the broader discussion around toxicant handling. However, there is still no good evidence showing that sulforaphane meaningfully reduces Parkinson’s-linked pesticide exposure in humans in a way that changes disease outcomes.

So the most defensible conclusion is narrow. Nutrition can help reduce incoming burden. Good dietary quality may support normal detoxification systems. A few compounds, including N-acetylcysteine and sulforaphane, have credible biological plausibility. But the current human evidence still supports exposure reduction much more strongly than it supports any supplement-led pesticide detoxification strategy for Parkinson’s disease (Hyland et al., 2019; Rempelos et al., 2022; Sajad et al., 2024).

Where the research still falls short

The biggest limitation in this field is still exposure assessment. Even strong geospatial studies are estimating exposure rather than directly measuring what entered a person’s body over decades (Paul et al., 2024). A second limitation is that “pesticides” remain a chemically diverse category, and lumping them together can blur meaningful differences (Shrestha et al., 2020). A third is that most nutrition-focused studies measure biomarkers of exposure rather than Parkinson’s disease outcomes (Hyland et al., 2019; Rempelos et al., 2022). These are not trivial limitations. They shape how strong the conclusions can be.

The bottom line

The fairest reading of the current literature is that pesticides remain among the most plausible environmental contributors to Parkinson’s disease risk, especially in some agricultural and occupational settings, and that this plausibility is strengthened by converging mechanistic evidence (Dorsey et al., 2025; Amaral et al., 2025). At the same time, the signal is not identical across all compounds, all exposure settings, or all study designs, and the field still has real measurement and causality problems to solve (Paul et al., 2024; Santos-Lobato et al., 2024).

For readers trying to work out what this means in real life, the most evidence-based message is not especially dramatic. Reduce exposure where feasible. Be selective about food sourcing when possible. Wash and handle produce sensibly. Avoid unnecessary household pesticide use. Be careful with claims that supplements can “detox” Parkinson’s-related pesticide risk. The science, at present, supports lowering the amount coming in more clearly than it supports any branded clean-up strategy after the fact.

How You Nutrition Clinic can help

At You Nutrition Clinic, this is exactly the kind of topic that benefits from a calm, evidence-led, personalised approach. We have a designated Parkinson's specialist RNTP who can support you with your diagnosis and work on some of those key symptoms that impact day to day life such as gut health issues, tiredness, sleep challenges and mood.

If you are living with Parkinson’s disease, supporting someone who is, or trying to make sense of environmental risk in a practical way, the aim is not to hand you a fear-based “detox plan.” It is to look carefully at likely exposure routes, food patterns, home environment, nutritional adequacy, digestive health, and current supplement use, and then build a plan that is proportionate, realistic, and rooted in science. For some people, that may begin with food sourcing and exposure reduction. For others, it may involve reviewing whether current supplements have any real rationale at all. Either way, the goal is the same: less noise, more precision, and support that stays close to what the evidence can genuinely justify.

To find out more about the support we offer, go to https://www.younutritionclinic.com/parkinsons

To schedule a free initial chat with Melody, please contact us either through the website contacts form or at admin@younutritionclinic.com.

🧩 Connect with us

For research updates, practical tips, and ongoing inspiration, follow us on Instagram:

👉 @nutritionandthebrain

👉 @younutritionkids

Stay curious. Stay hopeful. Support your brain. 🧠

Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. Always consult with a qualified, registered medical doctor (MD) for diagnosis and treatment decisions.

References

Amaral, L., Martins, M., Côrte-Real, M., Maciel, P., Fleming Outeiro, T., & Morais, V. A. (2025). The neurotoxicity of pesticides: Implications for Parkinson’s disease. Chemosphere, 377, 144348. https://doi.org/10.1016/j.chemosphere.2025.144348

Brown, E. G., Goldman, S. M., Coffey, C. S., et al. (2024). Occupational pesticide exposure in Parkinson’s disease related to GBA and LRRK2 variants. Journal of Parkinson’s Disease, 14(4), 737–746. https://doi.org/10.3233/JPD-240015

Dorsey, E. R., De Miranda, B. R., Hussain, S., et al. (2025). Environmental toxicants and Parkinson’s disease: Recent evidence, risks, and prevention opportunities. The Lancet Neurology, 24(11), 976–986. https://doi.org/10.1016/S1474-4422(25)00287-X

Fagan, J., Bohlen, L., Patton, S., & Klein, K. (2020). Organic diet intervention significantly reduces urinary glyphosate levels in U.S. children and adults. Environmental Research, 189, 109898. https://doi.org/10.1016/j.envres.2020.109898

Hasan, K. M. M., Barnhill, L. M., Paul, K. C., et al. (2025). The pesticide chlorpyrifos increases the risk of Parkinson’s disease. Molecular Neurodegeneration, 21(1), 3. https://doi.org/10.1186/s13024-025-00915-z

Hyland, C., Bradman, A., Gerona, R., Patton, S., Zakharevich, I., Gunier, R. B., & Klein, K. (2019). Organic diet intervention significantly reduces urinary pesticide levels in U.S. children and adults. Environmental Research, 171, 568–575. https://doi.org/10.1016/j.envres.2019.01.024

Medithi, S., Kasa, Y. D., Kankipati, V. R., Kodali, V., Jee, B., & Jonnalagadda, P. R. (2022). Impact of micronutrient supplementation on pesticide residual, acetylcholinesterase activity, and oxidative stress among farm children exposed to pesticides. Frontiers in Public Health, 10, 872125. https://doi.org/10.3389/fpubh.2022.872125

Meerman, J. J., de Bruijn, V. M. P., Luechtefeld, T., van Engelen, J. G. M., Kienhuis, A. S., & Heusinkveld, H. J. (2025). Including genetic susceptibility towards Parkinson’s disease in NAM-based hazard and risk assessment of pesticides: A semi-systematic review. NAM Journal, 1, 100036. https://doi.org/10.1016/j.namjnl.2025.100036

Morris, H. R., Spillantini, M. G., Sue, C. M., et al. (2024). The pathogenesis of Parkinson’s disease. The Lancet, 403(10423), 293–304. https://doi.org/10.1016/S0140-6736(23)01478-2

Paul, K. C., Cockburn, M., Gong, Y., Bronstein, J. M., & Ritz, B. (2024). Agricultural paraquat dichloride use and Parkinson’s disease in California’s Central Valley. International Journal of Epidemiology, 53(1), dyae004. https://doi.org/10.1093/ije/dyae004

Rempelos, L., Wang, J., Barański, M., et al. (2022). Diet and food type affect urinary pesticide residue excretion profiles in healthy individuals: Results of a randomized controlled dietary intervention trial. The American Journal of Clinical Nutrition, 115(2), 364–377. https://doi.org/10.1093/ajcn/nqab308

Saito, A., et al. (2025). Sulforaphane as a potential therapeutic agent: A comprehensive analysis of clinical trials and mechanistic insights. Journal of Nutritional Science, 14, e113. https://doi.org/10.1017/jns.2025.33

Sajad, M., Khan, M. A., Ahmad, N., et al. (2024). Role of nutraceutical against exposure to pesticide residues: Power of bioactive compounds. Frontiers in Nutrition, 11, 1396864. https://doi.org/10.3389/fnut.2024.1396864

Santos-Lobato, B. L., Romo, L., Schaffner, S. L., et al. (2024). Exposure to household pesticides and Parkinson’s disease in the Parkinson’s Progression Markers Initiative cohort. Frontiers in Neurology, 15, 1411468. https://doi.org/10.3389/fneur.2024.1411468

Shrestha, S., Parks, C. G., Umbach, D. M., et al. (2020). Pesticide use and incident Parkinson’s disease in a cohort of farmers and their spouses. Environmental Research, 191, 110186. https://doi.org/10.1016/j.envres.2020.110186

Singh, J., Singh, D., & Kaur, R. (2025). N-acetylcysteine as a potential therapeutic agent against toxicity of pesticides. Toxicology Mechanisms and Methods. https://doi.org/10.1080/15376516.2025.2496806

U.S. Environmental Protection Agency. (2023). Protect your family from pesticide exposure.

U.S. Environmental Protection Agency. (2025). Paraquat dichloride.

U.S. Environmental Protection Agency. (2025). Pesticides and food: Healthy, sensible food practices.